Fundraising FoxEczacibasi Momentum Teknoloji Yatimlari — Full Portfolio
12 tracked investments · listed companies and verified rows first
Digital health platform using AI to analyze video, audio, image and device data in the operating room to improve surgical outcomes and patient safety.
HealthtechBoston, US
Bjoern von Siemens(Executive Officer, Director)inDennis Kogan(Executive Officer, Director)Filip Pintelon(Director)inWerner Zoellner(Director)Paul Summerside(Director)Timothy Lantz(Executive Officer)
Co-investorsEckuityHarmonix FundIntel CapitalLauxera Capital PartnersNeventa CapitalOptum Ventures+2 more
Figopara is a Turkish financial technology platform that digitizes financial processes between commercial businesses and banks, letting companies convert invoices and checks into cash before maturity and compare financing offers from multiple financial institutions.
AI & Machine LearningFintechSaaS
Koray Gultekin Bahar(Founder)inArman Eker(Founder)inAhmet Bilgen(Founder)Ayhan Boyacioglu(Founder)Bulut Arukel(Founder)
Co-investorsFinbergSabancı VenturesDeBa VenturesLima VenturesMetis VenturesScaleX Ventures+2 more
Kunduz provides personalized tutoring to students through a combination of vetted tutors and AI, available 24/7.
AI & Machine LearningEdTechMarketplacesIstanbul, TR
Basar Basaran(Founder)inBaris Bilgic(Founder)inMelih Sener(Founder)inJordana Fremed(Head of Finance)Pelin Civan(People \u0026 Culture Lead)Gabriella Marasco(US Expansion Lead)
Co-investorsDorm RoomStartupFonVela PartnersVenture SolutionsY Combinator9Yards Capital+8 more
RS Research develops polymer-drug conjugates for targeted chemotherapy and theranostics in oncology, aiming to improve the therapeutic index in cancer treatment.
AI & Machine LearningBiotechMedical Devices
Prof. Rana Sanyal(Co-Founder)
Co-investorsACT Venture Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ChariEcomercekKeleyaNewlabOconTikoVagustimVirasoft
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.